Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
09-Jun-2011 -
Oxford BioMedica plc announced that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and therapeutic applications, to engineer an in vivo diagnostic imaging agent ...
antibodies
antibody fragments
ImaginAb
+3